Background: In preimplantation mouse embryos, the first cell fate specification to the trophectoderm or inner cell mass occurs by the early blastocyst stage. The cell fate is controlled by cell position-dependent Hippo signaling, although the mechanisms underlying position-dependent Hippo signaling are unknown. Results: We show that a combination of cell polarity and cell-cell adhesion establishes position-dependent Hippo signaling, where the outer and inner cells are polar and nonpolar, respectively. The junction-associated proteins angiomotin (Amot) and angiomotin-like 2 (Amotl2) are essential for Hippo pathway activation and appropriate cell fate specification. In the nonpolar inner cells, Amot localizes to adherens junctions (AJs), and cell-cell adhesion activates the Hippo pathway. In the outer cells, the cell polarity sequesters Amot from basolateral AJs to apical domains, thereby suppressing Hippo signaling. The N-terminal domain of Amot is required for actin binding, Nf2/Merlin-mediated association with the E-cadherin complex, and interaction with Lats protein kinase. In AJs, S176 in the N-terminal domain of Amot is phosphorylated by Lats, which inhibits the actin-binding activity,
Introduction
During preimplantation development, mouse embryos form blastocysts that comprise two cell types: the outer epithelial trophectoderm (TE) layer and the inner cell mass (ICM). TE is required for implantation and later contributes to the placenta. ICM further differentiates into the pluripotent epiblast, which later forms the embryo proper and the primitive endoderm.
Historically, two models have been proposed for the first cell fate specification process: the inside-outside (or positional) model [1] , in which the cell position within the embryo specifies the cell fate, and the polarity model [2] , in which the acquisition of cell polarity at the eight-cell stage is a critical step in the establishment of differential cell fates. The polarity model was further developed to include the promotion of TE fate based on the presence of the apical domain [3, 4] . We recently found that Hippo signaling pathway components, i.e., the TEAD family transcription factor Tead4 [5] [6] [7] , its coactivator proteins Yap (encoded by Yap1) and Taz (encoded by Wwtr1), and the protein kinases Lats1/2, play critical roles in this cell fate specification process [6, 8] . In the inner cells, cell-cell adhesions activate Hippo signaling, which inactivates Tead4 by suppressing the nuclear accumulation of Yap. In the outer cells, weak Hippo signaling facilitates the nuclear accumulation of Yap. The resulting active Tead4-Yap complex induces the TE-specific transcription factors Cdx2 and Gata3, which promote differentiation into TE [6, 9] . Therefore, establishment of position-dependent Hippo signaling is a critical step during differential cell fate specification, which supports the inside-outside model [6, 8] . We previously proposed that a possible mechanism for differential Hippo signaling may be differences in the degrees of cell-cell contacts between the inner and outer cells [6] . However, the exact mechanisms underlying position-dependent Hippo signaling remain largely unknown.
In support of the polarity model, several recent studies have suggested the importance of cell polarity during TE development. The Par-aPKC system plays central roles in the regulation of the apicobasal polarity of cells (see reviews in [10] [11] [12] ). Knockdown of Pard6b resulted in the reduced expression of Cdx2 and the failure of functional TE formation [13] . The complete absence of E-cadherin disrupted cell polarization, while the membrane localization of PKCz correlated with the nuclear accumulation of Yap and the expression of Cdx2 [14] . These observations suggest that cell polarity is probably important for cell fate specification and the regulation of Hippo signaling in preimplantation embryos. Studies in Drosophila also suggest that the cell polarity regulators Crumbs and aPKC control Hippo signaling in epithelial cells (legend continued on next page) [15] [16] [17] [18] , although the relationships between cell polarity and the Hippo activation status are opposite in fly epithelial cells and preimplantation embryos. Thus, the exact roles and mechanisms of cell polarity during the regulation of Hippo signaling in preimplantation embryos remain unknown. The Hippo pathway is controlled by various stimuli (see reviews and references in [19] [20] [21] ). Cell-cell adhesion is an important activation signal for the Hippo pathway, although the mechanisms that connect junctions to Hippo signaling remain largely unknown. Angiomotin (Amot)-family proteins (Amot, angiomotin-like 1 [Amotl1]/JEAP, and angiomotin-like 2 [Amotl2]/MASCOT [22] ) are Hippo signaling components [23, 24] that bind to the tight junction proteins MUPP1/Patj [25, 26] . Amot proteins also bind to Yap/Taz and the Nf2 tumor suppressor protein Merlin [23, 24, 27, 28] . Therefore, Amot is a potentially important protein that may connect junctions and the Hippo pathway.
In this study, we analyzed the roles of cell polarity during regulation of Hippo signaling in preimplantation embryos. We found that a combination of cell polarity and cell-cell adhesion established position-dependent Hippo signaling. We also found that phosphorylation of Amot at adherens junctions (AJs) stabilized its interaction with Lats and activated the Hippo pathway. Thus, cell polarity control through the junctional localization of Amot is the molecular basis for establishment of cell position-dependent Hippo signaling and the regulation of cell fate.
Results

Combination of Cell Polarity and Cell Adhesion Establishes Position-Dependent Hippo Signaling in Preimplantation Embryos
To examine the role of cell polarity during the regulation of Yap, we initially focused on the apical domain regulator aPKC-Par6-Par3 complex, which we disrupted by knocking down Pard6b via pronuclear injection of short hairpin RNA (shRNA) expression plasmids. As demonstrated previously [13] , shPard6b clearly reduced Pard6b proteins around the 32-cell stage, which disrupted the apical domain, as indicated by reduction in apically localized PKCl/z (n = 5/5) and p-ERM (n = 6/6) (Figure 1A ; see also Figure S1A available online). In contrast, the distributions of the basolateral regulators Scribble (n = 8/8) and Lgl1 (n = 3/3) were expanded into the outside domains ( Figure S1A, dots) .
In these apical domain-disrupted embryos, nuclear Yap signals were markedly reduced in the outer cells (n = 9/9, Figures  1A and 1B) . In this paper, Yap is used to describe Yap and Taz because the anti-Yap antibody detects both proteins. The activation of Hippo signaling promotes the phosphorylation of Yap (p-Yap), including the 112 th serine residue (S112) by Lats1/2 [29] . In normal embryos, the p-Yap signal or Hippo signaling is strong in the inner cells and weak in the outer cells ( Figures  1C and 1D ) [6] . In Pard6b knockdown (KD) embryos, the levels of p-Yap signals in the outer cells were increased to a level similar to that in the inner cells ( Figures 1C and 1D , n = 9/9). Consistent with the importance of Hippo signaling for cell fate control, Pard6b KD embryos had lower Cdx2 expression at the 32-cell stage ( Figures 1F and 1G) .
Essentially, the same results were obtained after suppressing PKCl/z activity through overexpression of dnPKCl (the kinase activity-negative form of PKCl) [30] (Figure S1B) (Yap: n = 15/16; p-Yap: n = 8/9) and the genetic ablation of aPKC in PKCl 2/2 :PKCz 2/2 embryos ( Figure 1E , n = 3/3; Figures S1F and S1G) [31] . Overall, these results suggest that the presence of an apical domain suppresses Hippo signaling in the outer cells.
Disruption of the apical Par-aPKC complex activated the Hippo pathway. To understand whether this activation requires cell-cell adhesions, we dissociated 32-cell stage embryos and examined the distribution of Yap. To mark the original cell position within the embryos, we labeled the outer cells with the red fluorescent dye PKH26 before dissociation [32] ( Figure 1H ). The inner and outer cells of the normal undissociated embryos exhibited clear cytoplasmic and nuclear Yap, respectively ( Figures 1A and 1J ). When these embryos were dissociated, all the cells exhibited clear nuclear Yap, irrespective of the original cell position ( Figures 1I and 1J ). In the undissociated Pard6b KD embryos, 84% of the outer cells had cytoplasmic Yap (Figures 1A and 1L ). After the Pard6b KD embryos were dissociated, the majority of the outer and inner cells exhibited nuclear Yap or nuclear and cytoplasmic Yap ( Figures 1K and 1L ). These results suggest that cell adhesion is required for all blastomeres to exclude Yap from the nuclei. Therefore, in the outer cells of normal embryos, the presence of the apical domain or the operation of the Par-aPKC system inhibits the activation of the Hippo pathway via cell-cell adhesion.
The Hippo Pathway Component Amot Has a Cell Position-Dependent Differential Distribution Amot is a junction-associated Hippo pathway component [23, 24] . There are two isoforms of Amot protein: p130 Amot (Amot130) and p80 Amot (Amot80), the latter lacking the N-terminal portion of Amot130 [33] (Figure 4A ). We focused on Amot130, which we refer to as Amot unless stated otherwise. Yeast two-hybrid screening of Amot-interacting proteins identified Yap. Like other researchers, we found that multiple Hippo pathway components, including Merlin, Lats2, and Kibra, also bind to Amot [23, 24, 27, 28] (Figures 4D, 4E , and S4A-S4C).
In the 32-cell stage, Amot proteins had different subcellular distributions in the inner and outer cells (Figure 2A ). In the outer cells, Amot was localized to the apical membrane and was not present in the basolateral membrane. In the inner cells, Amot was distributed throughout the plasma membrane and weakly in the cytoplasm. The polarized Amot distribution in the outer cells was established via cell polarization during compaction of the eight-cell stage embryos (Figures 2A and S2A ). The cell position-dependent differential distribution of Amot was Figure S1 for related data.
established after formation of the inner cells during the 16-cell stage, and this difference was maintained until the early blastocyst stage (Figure 2A ). The absence of Amot protein from the basal membrane of polarized cells was detected in the outer cells of the blastocysts (Figure 2A) .
Importantly, the presence of Amot proteins in the apical membrane or throughout the plasma membrane was always correlated with the presence of Yap in the nuclei or in the cytoplasm, respectively (Figures 2A and 2D ). In the outer cells, Amot was present at tight junctions, where it overlapped with two major junction proteins, ZO-1 and E-cadherin (Figure 2B ). In the inner cells, Amot colocalized with ZO-1 and E-cadherin ( Figure 2C ), which suggested that Amot was present in the vicinity of AJs. Of the junctional Hippo components, these correlations were probably specific to Amot, because three other Hippo components, i.e., Merlin, Kibra, and a-catenin, were present throughout the plasma membrane ( Figures S2B-S2D ).
The Par-aPKC System Controls the Distribution of Amot Amot localized to the apical domains in polarized cells, and thus, we examined the role of the apical regulator, ParaPKC, during the regulation of Amot. In embryos expressing dnPKCl, the apical restriction of Amot was absent from the outer cells. Amot was also present in the basolateral membrane, similar to the inner cells (n = 4/4) ( Figure 2E ). Pard6b KD embryos produced the same results (n = 17/18) ( Figure 2F ). Thus, the subcellular distribution of Amot was controlled by the apical Par-aPKC complex.
The activity of the apical Par-aPKC complex is suppressed by the basolateral regulator Par1 [10] , and thus, we examined the effects of downregulating two Par1 proteins, Par1a and Par1b, by coinjecting shRNA plasmids for Par1a/b (Figure S2E ). Par1a/b double knockdown (DKD) embryos exhibited no apparent changes in apically localized PKCl/z (n = 6/7) and Pard6b (n = 6/6) or the basolateral localization of E-cadherin (n = 6/6) ( Figure S2F ). However, the Amot distribution was changed (n = 7/7), and Amot was present in the lateral membrane of the outer cells, thereby mimicking the inner cells ( Figure 2G ). The importance of the junctional localization of Amot in the Hippo pathway activation was supported further because Yap was excluded from the nuclei of the outer cells (n = 7/10) ( Figures 2D and 2G ), while the phosphorylation of Yap was increased in the outer cells (n = 3/3) ( Figure 2G ). These results suggest that the Par-aPKC system, including Par1, controls the junctional localization of Amot and Hippo signaling in the outer cells.
Amot-Family Proteins Are Required for Activation of the Hippo Pathway
To examine the role of Amot, we used Amot mutant embryos [34] . Amot null mutant embryos (Amot In the later stages, however, the inner cells of most Amot mutants exhibited moderate nuclear Yap (Figures 3A and 3F), and Amot mutants survived until the postimplantation stages [34] . There are two other Amot-family genes, Amotl1 and Amotl2, and thus, we hypothesized that these proteins may also play roles in the regulation of Yap. Indeed, Amotl2 (but not Amotl1) was expressed ( Figure 3C ; data not shown). In wild-type embryos, Amotl2 was localized only to the apical membrane of the outer cells ( Figure 3C ). However, in Amot mutant embryos, it was interesting that Amotl2 also localized to the plasma membrane of the inner cells, similar to Amot ( Figure 3C ).
To examine the role of Amotl2, we knocked down Amotl2 by siRNA injection. In Amotl2 KD embryos, Amotl2 protein was clearly reduced, but these embryos exhibited a normal Yap distribution and Hippo pathway activation, which was monitored based on p-Yap ( Figures S3B and S3C) . However, when Amotl2 KD was performed with Amot mutants, these embryos, which we describe as Amot-free embryos, exhibited strong nuclear localization of Yap in the inner cells, even in the later stages (n = 30/30) ( Figures 3D and 3F) , and the activation of the Hippo pathway was almost completely lost (n = 7/7) (Figure 3E) . Therefore, Amot-family proteins are essential for the activation of the Hippo pathway in preimplantation embryos, where Amot and Amotl2 play major and supplementary roles, respectively. Consistent with the idea that cell polarity acts upstream of Amot, Amot-free embryos had a normal distribution of PKCl/z (n = 5/5) ( Figure S3D ).
At E4.5, the Amot-free embryos exhibited two morphological types: a blastocyst-like morphology (type I) and a cyst lacking inner cells (type II). In both types, all the cells strongly expressed the TE regulator Cdx2 (n = 27/27) ( Figures 3G, 3H , and S3E). Two similar phenotypes were also observed with Lats1/2 double mutants, in which the Hippo pathway was inactive ( Figure S3F ) [6] . In Amot-free embryos, the expression of the epiblast marker Nanog was lost or significantly reduced (n = 2/2) ( Figure 3G ), while expression of the primitive endoderm marker Gata6 was lost (n = 3/3) ( Figure 3H ). Formation of blastocoels in Amot-free embryos suggested the formation of functional TE because Tead4 2/2 and Pard6b KD embryos, which lacked TE, failed to form blastocoels. Therefore, activation of the Hippo pathway by Amot-family proteins is critically important for appropriate cell fate specification. 4C ). The expressed Amot proteins had similar distribution patterns to the endogenous proteins ( Figure 4B ). Overexpression of Amot led to the formation of abnormal F-actin-mediated aggregates in the cytoplasm and the nuclear exclusion of Yap in the outer cells (data not shown). Therefore, we used the same RNA dose for all constructs to ensure that they were expressed at physiological levels.
Expression of Amot80, which lacks the N-terminal domain, failed to rescue the Amot-free phenotype ( Figures 4A-4C) . The Amot80 protein level was low, and the localization of Amot80 to inner cell AJs was not seen clearly ( Figure 4B ). Expression of Amot-DCC, which lacks the central coiled-coil domain, also failed to rescue Amot-free embryos ( Figures  4A-4C ). In this case, however, Amot-DCC proteins were abundant, including AJs. These results suggest that the N-terminal and coiled-coil domains are both required for activation of the Hippo pathway, while the N-terminal domain is required for the localization of Amot proteins to AJs and probably to maintain their stability. It appears that Amot is stabilized in the AJs of Hippo-active cells. The role of the coiled-coil domain in the Hippo pathway activation is distinct from that in the N-terminal domain.
The N-terminal domain contains three PY motifs. The first two PY motifs interact with NEDD4-like E3 ubiquitin ligase [35] motif interacts with Kibra ( Figures S4B and S4C) . Amot also interacts with the junctional proteins MUPP1/Patj via the C-terminal PDZ domain-binding motif [25, 26] . To examine the importance of these motifs, we also expressed AmotmPY123, which had mutations in all three PY motifs, and Amot-DPDZbd, which lacked the C-terminal PDZ domainbinding motif, in Amot-free embryos ( Figure 4A ). The rescue activities of Amot-mPY123 and Amot-DPDZbd appeared to be weaker than that of unmodified Amot, but they clearly rescued the mutant phenotype ( Figures 4B and 4C) , thereby indicating that these motifs do not play critically important roles by themselves.
The Figure 4D ). When overexpressed, Amot80 also interacted with Lats2, but this interaction was clearly weaker than that with Amot130 (Figure S4D ). Amot-DCC did not interact with Lats2 ( Figure 4E) . Therefore, the functionally important N-terminal and coiledcoil domains are both required for the strong interaction between Amot and Lats2.
The N-Terminal Domain Is Also Required for the Actin-Binding Activity and the Merlin-Mediated Interaction with the E-Cadherin Complex Amot80 did not exhibit strong signals in AJs ( Figure 4B ), and thus, we examined the molecular basis of this result. Consistent with a previous report that the N-terminal domain of Amot interacts with and promotes the formation of F-actin [37] , Amot130-expressing HEK293T and NIH 3T3 cells formed thick F-actin bundles where Amot130 colocalized, whereas Amot80 did not exhibit these activities (Figures 4F and S4E) . Therefore, the localization to AJs may involve binding to cortical actin fibers.
To further elucidate the relationship between Amot and AJs, we examined the interaction between Amot and the E-cadherin complex. When E-cadherin was immunoprecipitated from cell lysates coexpressing E-cadherin and Amot, weak coIP of Amot was observed ( Figure 4G ). Amot interacts with Merlin [28] , which also interacts with a-catenin, a core component of cadherin complexes [38] . Thus, we hypothesized that the interaction between Amot and the E-cadherin complex involved Merlin. As expected, coexpression of Merlin enhanced coIP of Amot and E-cadherin ( Figure 4G ). Amot interacts directly with Merlin via its coiled-coil domain [28] . In support of the importance of its interaction with Merlin, Amot-DCC did not interact with E-cadherin ( Figure 4G ). We also observed weak coIP of Amot80 and E-cadherin, but no enhancement was observed by the coexpression of Merlin ( Figure 4G ; data not shown). Amot130 and Amot80 contain the coiled-coil domain, and thus, the N-terminal domain has accessory roles that stabilize its interaction with the E-cadherin complex.
Amot also had weak coIP with E-cadherin-DC, which lacked the b-catenin interaction domain [39, 40] (Figure 4H ). The interaction of a-catenin with cadherin requires b-catenin, and thus, this result suggested that a catenin-independent mechanism was also involved in the interaction between Amot and E-cadherin. Consistent with the hypothesis that Merlin cooperates with a-catenin, Merlin did not interact with E-cadherin-DC, and the interaction between Amot and E-cadherin-DC was not enhanced by Merlin ( Figure 4H ). Overall, these results suggest that the N-terminal domain of Amot is essential for its strong interaction with Lats2 for actin binding and for the strong Merlin-dependent interaction with the E-cadherin complex.
Phosphorylation of the Lats Target Site in Amot, S176, Activates the Hippo Pathway The N-terminal domain of Amot-family proteins possesses a sequence, HVRSLS, which matches the consensus motif for the Lats phosphorylation site HxRxxS [29, 41] . The 176 th serine residue (S176) in this Amot motif is a possible Lats phosphorylation site ( Figure 5A ). We generated an antibody that recognized phosphorylated S176 specifically (p-S176). In the western blot analysis, this antibody detected Amot, but not the nonphosphorylatable mutant Amot-S176A ( Figure 5B) . In preimplantation embryos, this antibody produced signals in the inner cell AJs ( Figure 5C ). These signals were not observed in the embryos treated with l phosphatase or Amot-free embryos ( Figure 5D ), which indicated that the antibody specifically detected phosphorylated Amot (p-S176-Amot).
Western blot analysis of cell lysates expressing Lats2 or kinase activity-negative Lats2 (Lats2-KN) detected Lats activitydependent phosphorylation of S176 ( Figure 5E ). In embryos, junction-localized p-S176-Amot was not detected in Lats1/2 DKD embryos but was ectopically observed in Lats2-overexpressing embryos ( Figure 5F ). These results suggest that Lats phosphorylated S176 in Amot in the AJs of the inner cells.
p-S176-Amot localized to the AJs of the Hippo-active inner cells, and thus, we examined the role of this phosphorylation in the Hippo pathway activation. RNA injection into Amot-free embryos showed that the nonphosphorylatable mutant Amot-S176A had the very weak rescue activity of the mutant phenotype ( Figures 5G-5I) . The inner cells exhibited nuclear Yap, and the p-Yap signal remained very low ( Figure 5H ). Similar to Amot80, the level of Amot-S176A was low, and no clear signal was observed in the AJs ( Figure 5H ). In contrast, a phosphomimetic mutant, Amot-S176E, excluded Yap from the inner cell nuclei (Figures 5G-5I) . Importantly, Yap was also excluded from the outer cell nuclei, which suggests that Amot-S176E is a constitutively active protein, although the degree and frequency of nuclear exclusion in the outer cells were lower than those in the inner cells ( Figures 5H and 5I ). Ectopic activation of Hippo signaling was also confirmed by increased p-Yap signals ( Figure 5H ). The Amot-S176E proteins formed dense discrete dots on the plasma membranes ( Figure 5H ). These results suggest that the phosphorylation of S176 has critically important roles in controlling the functions of the N-terminal domain: localization/stabilization in the AJs and the activation of the Hippo pathway. Therefore, the phosphorylation of S176 in Amot is important for Hippo pathway activation in AJs.
Phosphorylation of S176 Suppresses the Actin-Binding Activity of Amot To determine the molecular basis of Hippo pathway activation via the phosphorylation of S176, we investigated how this phosphorylation modifies the molecular properties of Amot. First, we examined the actin-binding activity. In HEK293T and NIH 3T3 cells, Amot-S176A had actin polymerization and binding activities similar to Amot, whereas Amot-S176E had neither activity (Figures 6A and S5A) . Therefore, nonphosphorylated Amot binds to actin, and the phosphorylation of S176 suppresses its actin-binding activity. 
Phosphorylation of S176 Does Not Affect the Merlin-Dependent Interaction between Amot and the E-Cadherin Complex
We examined the effects of S176 phosphorylation on the interaction between Amot and the E-cadherin complex. Amot-S176A and Amot-S176E had Merlin-dependent interactions with E-cadherin ( Figure S5B) . Therefore, the phosphorylation status of S176 did not have significant effects on the interaction between Amot and the E-cadherin complex.
Phosphorylation of S176 in Amot Is Required for Its Strong Interaction with Lats
Finally, we examined the effects of S176 phosphorylation on the interaction between Amot and Lats2. In coIP experiments, Amot-S176A and Amot-S176E had weak and strong interactions with Lats2, respectively ( Figure 6B) . Therefore, the phosphorylation of S176 is required for the strong interaction with Lats2. Consistent with the idea that S176 is a Lats target site, Amot did not have clear interaction based on coIP from the lysates of cells cotransfected with Amot and Lats2-KN (Figure 6C ). In this system, Amot-S176E had a strong interaction with Lats2-KN ( Figure 6C ). These results suggest that the phosphorylation of S176 by Lats enhances the interaction between Amot and Lats.
Strong Correlations between Lats Binding, Protein Stability at AJs, and Hippo Pathway Activation
Further support of the importance of S176 phosphorylation was provided by the correlations between Lats binding, the in vivo protein stability at AJs, and mutant rescue activity using two additional deletion mutants of Amot. One mutant, Amot-D(45-100), had a strong interaction with Lats2 ( Figures 6D  and 6E ). In rescue experiments, Amot-D(45-100) protein was abundant, including in AJs, where S176 was phosphorylated, and the embryos exhibited clear nuclear exclusion of Yap, which was an indication of the strong activation of the Hippo pathway, in all cells ( Figures 6F and 6G ). Amot-D(45-100) activated the Hippo pathway without disturbing the cell polarity, which was demonstrated by apically localized PKCl/z (Figure S5C) . The second mutant, Amot-D(101-141), which had only a very weak interaction with Lats2 ( Figures 6D and 6E ), was not detected in embryos and failed to rescue the mutant phenotype ( Figures 6F and 6G) . Therefore, the phosphorylation of S176 by Lats is an important step during Hippo pathway activation in AJs, which includes protein stabilization in the AJs and a stable interaction with Lats.
Discussion
Combination of Cell Adhesion and Cell Polarity Converts Positional Information into Cell Fate via Hippo Signaling in Preimplantation Embryos
We previously showed that cell position-dependent Hippo signaling is the key mechanism underlying position-dependent cell fate specification in preimplantation embryos [6, 8] .
In the present study, we demonstrated the involvement of cell polarity and cell-cell adhesion with the regulation of Hippo signaling. In the outer cells, the presence of cell polarity or the operation of the Par-aPKC system suppressed the activation of the Hippo pathway via cell-cell adhesion. In the inner cells, the absence of cell polarity facilitated Hippo pathway activation via cell-cell adhesion, thereby leading to ''inside-ON, outside-OFF'' differential Hippo signaling in the embryo. This mechanism implies that cells in preimplantation embryos interpret their positional information via a combination of two cellular processes, i.e., cell polarity and cell-cell adhesion, to control their cell fate. Furthermore, this mechanism is consistent with the two historical models of the initial cell fate specification process: the inside-outside model [1] and the newer version of the polarity model [3, 4] .
A Model of Amot-Dependent Hippo Pathway Regulation in Preimplantation Embryos
At the molecular level, the localization of Amot-family proteins to AJs is essential for the activation of the Hippo pathway, while the cell polarity/Par-aPKC system controls the AJ localization of Amot. The roles of Amot in Hippo pathway activation and the establishment of position-dependent Hippo signaling are summarized in the following model ( Figure 6H ).
In the inner cells, (1) Amot localizes to AJs by binding to cortical F-actin and the E-cadherin complex by interacting with Merlin. E-cadherin and Amot are probably connected by a large complex of E-cadherin-b-catenin-a-catenin-MerlinAmot because Merlin interacts with a-catenin [38] and Amot [28] . In support of this model, Nf2/Merlin is required for activation of the Hippo pathway in preimplantation embryos (as seen in the work of Cockburn et al. [42] published in this issue of Current Biology). In this state, Amot is fairly unstable and is probably degraded via ubiquitination [35] . (2) Lats phosphorylates S176 in the AJ-associated Amot. The dimerization of E-cadherin [43] may contribute to Amot phosphorylation by promoting the dimerization and/or cross-phosphorylation of Lats [44, 45] . (3) p-S176-Amot is detached from cortical F-actin and is stabilized in the AJs. p-S176-Amot also forms a stable complex with Lats, which activates the Hippo pathway, probably by activating Lats. This may not be the only mechanism, but the phosphorylation of S176-Amot is an important molecular switch that turns on the Hippo pathway in AJs.
In the outer cells, the operation of the Par-aPKC system sequesters Amot from the basolateral AJs to the apical membrane domain. AJs lack the essential switching protein, Amot, and thus, AJs do not activate Lats, and the Hippo pathway remains inactive. Nonphosphorylated Amot probably binds to apical actin bundles. The mechanism by which cell polarity restricts Amot remains to be elucidated. The direct/indirect interaction of Amot with the polarity regulators Par3 and Crumbs and the junctional proteins Patj/MUPP1 [25, 26, 46] probably contributes to the regulation of the subcellular localization of Amot.
General Roles of Amot in the Hippo Pathway
How general are the mechanisms described above? An Amotmediated mechanism does not operate in Drosophila because it lacks a homolog [22] . In mammals, the roles of Amot appear to differ in epithelial cells and preimplantation embryos. Amot is localized to the tight junctions of polarized epithelial cells and outer cells. However, the outer cells exhibit nuclear Yap, while the epithelial cells suppress nuclear Yap by activating the Hippo pathway and tethering Yap to tight junctions [23, 27, 36] . Despite these differences, Amot activates the Hippo pathway via Lats at intercellular junctions in the inner and epithelial cells [36] . The relationship between the cell polarity and Hippo pathway activation is opposite in these cell types, but there must be common activation mechanisms, which probably involve the phosphorylation of S176.
An important feature of Amot is its actin-binding activity, and we determined correlations between S176 phosphorylation, actin binding, Lats binding, and Hippo pathway activation. Figure S5 for related data. [47, 48] , and thus, it is intriguing to speculate that Amot is involved with the actin-mediated regulation of Hippo signaling. It is also likely that Hippo signaling controls F-actin by modulating the actin-binding/polymerization activity of Amot via phosphorylation. In this context, it is interesting to note that the apical domain of the outer cells of the preimplantation embryo, in which the Hippo pathway is inactive, contained a large amount of cortical F-actin.
Roles of Hippo Signaling during Cell Fate Specification in Preimplantation Embryos
In the context of preimplantation embryos, two important questions need to be addressed in future. Cell polarization is the first important step during the establishment of positiondependent Hippo signaling. Therefore, the first question is, what promotes the initial polarization of the outer cells, either in the early embryo or in isolated ICMs [49] ? The second question is, what is the relationship between the Hippo-regulated mechanism and other mechanisms during initial cell fate specification? Several different mechanisms are known to operate, including very early biases among blastomeres and polarity-dependent asymmetric segregation of mRNAs (see the reviews and references in [50, 51] ). Irrespective of the operation of these mechanisms, the experimental manipulation of 16-cell and 32-cell stage embryos demonstrated the complete and partial adjustment of cell fates, respectively, with new cell positions [32] . Therefore, the continuous operation of positiondependent Hippo signaling after the 16-cell stage probably has central roles in cell fate specification by generating, enhancing, and stabilizing position-dependent differences throughout preimplantation development. However, it is important to clarify the relationship among these different mechanisms during normal developmental processes.
Experimental Procedures
Housing of Mice Mice were housed in environmentally controlled rooms in the Laboratory Animal Housing Facility at the RIKEN Center for Developmental Biology (CDB) and the Center for Animal Resources and Development (CARD) at Kumamoto University. All experiments were performed according to the regulations for animal and recombinant DNA experiments at RIKEN CDB and Kumamoto University and the laws and notifications of the Japanese government. All experiments were also approved by the institutional committees for animal and recombinant DNA experiments at RIKEN CDB and Kumamoto University.
Mouse Lines
Wild-type embryos were obtained by intercrossing (C57BL/6xDBA)F1 (BDF1) or by crossing ICR female with BDF1 male mice. The Amot mutant (CDB accession no. CDB0089K; http://www.cdb.riken.jp/arg/ mutant%20mice%20list.html) [34] and PKCl mutant [31] mice were described previously. PKCz mutant mice were generated via homologous recombination in ES cells. Detailed procedures for the production of PKCz mutant mice and genotype determination are provided in the Supplemental Experimental Procedures.
DNA/RNA Injection into Preimplantation Embryos
Poly(A)-tailed RNA was injected into both blastomeres of two-cell stage embryos, as described previously [6] . An RNA concentration of 25 ng/ml was used in the rescue experiments. To achieve gene knockdown by the injection of siRNAs, we injected Stealth RNAi siRNAs (Invitrogen) into both blastomeres of two-cell stage embryos at a concentration of 8 mM. The purified and verified shRNA plasmid DNA solution (10 ng/ml) was injected into the male pronuclei using standard protocols [13, 52] . The embryos were cultured for 48 hr and 80 hr after injection to analyze 32-cell and late blastocyst stage embryos, respectively. Details of the plasmids and siRNAs used as well as other embryo manipulations are provided in the Supplemental Experimental Procedures.
Immunofluorescent Staining and Data Acquisition
Immunofluorescent staining of preimplantation embryos and transfected cells was performed as described previously [6, 53] with slight modifications. Goat anti-mouse, anti-rabbit, and anti-rat IgG antibodies labeled with Alexa Fluor 488, Alexa Fluor 555 (Invitrogen), or DyLight 649 (Jackson ImmunoResearch) were used as the secondary antibodies. Hoechst 33258 stain (Dojindo Molecular Technologies) was used for nuclear staining. Images were acquired using confocal laser scanning microscopes LSM510META (Zeiss) or A1 (Nikon). Details of the analyses of the acquired images are provided in the Supplemental Experimental Procedures.
Immunoprecipitation Immunoprecipitation (IP) was performed according to previously described procedures [54] , with slight modifications. In brief, expression plasmids (0.8 mg) were transfected into 6 3 10 5 HEK293T cells plated onto six-well plates. One day after transfection, the cells were lysed with 0.5 ml of high salt RIPA buffer (50 mM Tris-HCl [pH 8.0], 500 mM NaCl, 1% NP-40, 0.5% deoxycholic acid, and 0.1% SDS) supplemented with complete protease inhibitor cocktail (Roche). Genomic DNA was disrupted by sonication. The lysate was centrifuged at 12,000 3 g for 10 min, and the supernatant was diluted with 0.5 ml of NaCl-free RIPA buffer. The resulting diluted lysates were used as samples for IP. In all of the IP experiments, FLAG-tagged proteins were precipitated using anti-FLAG M2-agarose (Sigma). All the procedures were performed at 4 C or on ice.
Statistical Analysis
All statistical analyses were performed using Prism5 (GraphPad). Student's t test was used for comparisons between two groups.
Supplemental Information
Supplemental Information includes five figures and Supplemental Experimental Procedures and can be found with this article online at http://dx. doi.org/10.1016/j.cub.2013.05.014.
